Literature DB >> 6745855

Evidence for valine intolerance in patients with cirrhosis.

P Schauder, K Schröder, L Herbertz, K Langer, U Langenbeck.   

Abstract

Valine (62.5 mg per kg), leucine (70 mg per kg) and equal amounts of the calcium salts of the corresponding keto acids, i.e., alpha-ketoisovaleric acid (KIVA) and alpha-ketoisocaproic acid (KICA) were orally administered to patients with cirrhosis and to control subjects. Valine or leucine ingestion increased serum valine and leucine levels and the corresponding keto acids, KIVA and KICA, in cirrhotics and controls. KIVA or KICA ingestion increased serum KIVA and KICA concentrations within a few minutes associated with a rise in valine and leucine. In cirrhotics, administration of valine or KIVA resulted in significantly higher serum valine or KIVA concentrations than in control subjects. The clearance of valine and KIVA from blood was also delayed in cirrhotic patients. No such differences were observed after leucine or KICA ingestion. It is suggested that cirrhotics have a diminished tolerance for valine. Since the tolerance for KIVA, but not KICA, is also impaired, it appears that cirrhotics have a derangement in one or more metabolic steps distal to the branched-chain keto acid dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6745855     DOI: 10.1002/hep.1840040417

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  3 in total

1.  Muscle wasting and branched-chain amino acid, alpha-ketoglutarate, and ATP depletion in a rat model of liver cirrhosis.

Authors:  Milan Holeček; Melita Vodeničarovová
Journal:  Int J Exp Pathol       Date:  2019-01-13       Impact factor: 1.925

2.  Changes in human hepatic metabolism in steatosis and cirrhosis.

Authors:  Zoe Schofield; Michelle Ac Reed; Philip N Newsome; David H Adams; Ulrich L Günther; Patricia F Lalor
Journal:  World J Gastroenterol       Date:  2017-04-21       Impact factor: 5.742

3.  Protein tolerance to standard and high protein meals in patients with liver cirrhosis.

Authors:  Octavio Campollo; Dirk Sprengers; Gitte Dam; Hendrik Vilstrup; Neil McIntyre
Journal:  World J Hepatol       Date:  2017-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.